SCHEMBL13638312

SCHEMBL13638312

C=C1CC(Nc2nccc(-c3ccc(CCCN)cc3)n2)CC(C)(C)N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 13/20 0.39
AKT2 P31751 1/20 0.37
CHUK O15111 2/20 0.37
MAPK8 P45983 3/20 0.36
AURKA O14965 1/20 0.35
TTK P33981 1/20 0.35
AURKB Q96GD4 1/20 0.35
INCENP Q9NQS7 1/20 0.35
ROCK2 O75116 3/20 0.35
MAPK9 P45984 2/20 0.34
MAPK10 P53779 2/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
CDK1 P06493 1/20 0.34
CDK4 P11802 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
CCND1 P24385 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638313 0.97 IKBKB (0.39) IKBKBAKT2CHUKMAPK8AURKA
SCHEMBL13638679 0.95 IKBKB (0.41) IKBKBCHUKMAPK8AURKATTK
SCHEMBL13638438 0.90 IKBKB (0.39) IKBKBCHUKMAPK8ROCK2MAPK9
SCHEMBL13638538 0.89 IKBKB (0.38) IKBKBCHUKMAPK8MAPK11MAPK14
SCHEMBL13638591 0.88 IKBKB (0.37) IKBKBCHUKMAPK8AURKATTK
SCHEMBL13638532 0.88 IKBKB (0.39) IKBKBCHUKMAPK8AURKATTK
SCHEMBL13638590 0.87 ROCK2 (0.38) IKBKBCHUKMAPK8AURKATTK
SCHEMBL3478406 0.87 IKBKB (0.42) IKBKBAKT2CHUKMAPK8AURKA
SCHEMBL13638437 0.86 IKBKB (0.39) IKBKBCHUKMAPK8MAPK9MAPK10
SCHEMBL13638531 0.86 SYK (0.43) IKBKBCHUKMAPK8ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed